The use of these H2R agonists could have been impaired by side effects such as acid production in the stomach (Felix et al., 1991a, 1995) or the assumption that all cAMP-increasing agents induce cardiac arrhythmias. This evidence concerns the gene HRH2 and chronic obstructive pulmonary disease.